CONMED Corporation
DE ˙ DB ˙ US2074101013
29,80 € ↑1,40 (4,93%)
2026-06-04
AKTIENPREIS
SecurityDE:EC8 / CONMED Corporation
InstitutionFmr Llc
Latest Disclosed Ownership1,038,072 shares
Ownership 3.75%
Fmr Llc ownership in EC8 / CONMED Corporation

2016-04-11 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,038,072 shares of CONMED Corporation (DE:EC8). This represents 3.745 percent ownership of the company. In their previous filing dated 2016-02-12 , Fmr Llc had reported owning 2,933,848 shares, indicating a decrease of -64.62 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2016-04-11 2016-04-11 13G/A 2,933,848 1,038,072 -64.62 3.75 -64.63
2016-02-12 2016-02-12 13G/A 3,037,071 2,933,848 -3.40 10.59 -3.42
2015-08-10 2015-08-10 13G/A 3,037,071 10.96
2015-02-13 2015-02-13 13G/A 1,958,247 7.11
2014-02-14 2014-02-14 13G 1,864,600 6.75

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CONMED COM 207410101 10,295 7,999 348.39 364 291.40 0.0000
2026-02-17 2025-12-31 13F CONMED COM 207410101 2,296 476 26.15 93 9.41 0.0000
2025-11-13 2025-09-30 13F CONMED COM 207410101 1,820 -496 -21.42 86 -29.17 0.0000
2025-08-14 2025-06-30 13F CONMED COM 207410101 2,316 1,027 79.67 121 55.84 0.0000
2025-05-12 2025-03-31 13F CONMED COM 207410101 1,289 -25,952 -95.27 78 -95.87 0.0000
2025-02-13 2024-12-31 13F CONMED COM 207410101 27,241 -43,748 -61.63 1,864 -63.49 0.0001
2024-11-13 2024-09-30 13F CONMED COM 207410101 70,989 -10,603 -13.00 5,106 -9.73 0.0003
2024-08-13 2024-06-30 13F CONMED COM 207410101 81,592 80,291 6,171.48 5,656 5,337.50 0.0004
2024-05-13 2024-03-31 13F CONMED COM 207410101 1,301 -1,362 -51.15 104 -64.26 0.0000
2024-02-13 2023-12-31 13F CONMED COM 207410101 2,663 37 1.41 292 10.23 0.0000
2023-11-13 2023-09-30 13F CONMED COM 207410101 2,626 -410,399 -99.36 265 -99.53 0.0000
2023-08-11 2023-06-30 13F CONMED COM 207410101 413,025 410,607 16,981.27 56,126 22,260.56 0.0047
2023-08-11 2023-03-31 13F/A-1 CONMED COM 207410101 2,418 1,185 96.11 251 130.28 0.0000
2023-05-11 2023-03-31 13F CONMED COM 207410101 2,418 1,185 251 0.0000
2023-02-13 2022-12-31 13F CONMED COM 207410101 1,233 274 28.57 109 41.56 0.0000
2022-11-10 2022-09-30 13F CONMED COM 207410101 959 225 30.65 77 8.45 0.0000
2022-08-12 2022-06-30 13F CONMED COM 207410101 734 -171 -18.90 71 -47.41 0.0000
2022-05-13 2022-03-31 13F CONMED COM 207410101 905 465 105.68 135 114.29 0.0000
2022-02-14 2021-12-31 13F CONMED COM 207410101 440 15 3.53 63 12.50 0.0000
2022-02-14 2021-09-30 13F/A-1 CONMED COM 207410101 425 83 24.27 56 19.15 0.0000
2021-11-15 2021-09-30 13F CONMED COM 207410101 425 83 56 0.0000
2021-08-13 2021-06-30 13F CONMED COM 207410101 342 -24 -6.56 47 -2.08 0.0000
2021-05-14 2021-03-31 13F CONMED COM 207410101 366 24 7.02 48 23.08 0.0000
2021-02-08 2020-12-31 13F CONMED COM 207410101 342 80 30.53 39 85.71 0.0000
2020-11-13 2020-09-30 13F CONMED COM 207410101 262 28 11.97 21 23.53 0.0000
2020-08-24 2020-06-30 13F/A-1 CONMED COM 207410101 234 -280 -54.47 17 -41.38 0.0000
2020-08-13 2020-06-30 13F CONMED COM 207410101 234 -280 17 0.4176
2020-05-14 2020-03-31 13F CONMED COM 207410101 514 -480,164 -99.89 29 -99.95 0.0000
2020-02-07 2019-12-31 13F CONMED COM 207410101 480,678 -16,580 -3.33 53,755 12.43 0.0059
2019-11-13 2019-09-30 13F CONMED COM 207410101 497,258 199,869 67.21 47,811 87.88 0.0057
2019-08-13 2019-06-30 13F CONMED COM 207410101 297,389 3,480 1.18 25,448 4.09 0.0030
2019-05-13 2019-03-31 13F CONMED COM 207410101 293,909 2,373 0.81 24,447 30.62 0.0029
2019-02-13 2018-12-31 13F CONMED COM 207410101 291,536 2,458 0.85 18,716 -18.27 0.0026
2018-11-09 2018-09-30 13F CONMED COM 207410101 289,078 2,298 0.80 22,901 9.09 0.0026
2018-08-10 2018-06-30 13F CONMED COM 207410101 286,780 286,780 20,992 0.0025
2017-02-10 2016-12-31 13F CONMED COM 207410101 0 0 0 0.0000
2016-11-14 2016-09-30 13F CONMED COM 207410101 0 -280,000 -100.00 0 -100.00
2016-08-11 2016-06-30 13F CONMED COM 207410101 280,000 -758,072 -73.03 13,364 -69.30 0.0018
2016-05-16 2016-03-31 13F CONMED COM 207410101 1,038,072 -1,895,776 -64.62 43,537 -66.31 0.0060
2016-02-12 2015-12-31 13F CONMED COM 207410101 2,933,848 -398,232 -11.95 129,236 -18.76 0.0174
2015-11-10 2015-09-30 13F CONMED COM 207410101 3,332,080 577,543 20.97 159,073 -0.89 0.0226
2015-08-25 2015-06-30 13F/A-1 CONMED COM 207410101 2,754,537 567,498 25.95 160,507 45.36 0.0206
2015-08-13 2015-06-30 13F CONMED COM 207410101 2,754,537 160,507
2015-05-14 2015-03-31 13F CONMED COM 207410101 2,187,039 228,792 11.68 110,424 25.42 0.0141
2015-02-17 2014-12-31 13F CONMED COM 207410101 1,958,247 -19,519 -0.99 88,043 20.84 0.0115
2014-11-14 2014-09-30 13F CONMED COM 207410101 1,977,766 75,419 3.96 72,861 -13.25 0.0099
2014-08-14 2014-06-30 13F CONMED COM 207410101 1,902,347 -389,997 -17.01 83,989 -15.68 0.0113
2014-05-15 2014-03-31 13F CONMED COM 207410101 2,292,344 427,744 22.94 99,602 25.69 0.0138
2014-02-13 2013-12-31 13F CONMED COM 207410101 1,864,600 197,000 11.81 79,246 39.81 0.0112
2013-11-14 2013-09-30 13F CONMED COM 207410101 1,667,600 54,600 3.38 56,682 12.49 0.0087
2013-09-24 2013-06-30 13F/A-1 CONMED COM 207410101 1,613,000 1,613,000 50,390 0.0082
2013-08-14 2013-06-30 13F CONMED COM 207410101 1,613,000 50,390 0.0082
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.